C3i Appoints Jonathan Song to Business Development Executive in Asia

SHANGHAI and DALIAN, China, July 16, 2012 /PRNewswire-USNewswire/ -- C3i, the leader in service desk support and business process outsourcing (BPO) services for the life sciences industry, announced today the appointment of Jonathan Song to business development executive in Asia.

C3i provides end-user technology training, multi-lingual service desk and configuration and deployment for mobile application hardware, including iPad/iPhone to life science organizations worldwide.  C3i works with 16 of the top 20 pharmaceutical and biotechnology firms and has supported over 1,000,000 life sciences professionals and patients worldwide in over 20 languages.  C3i has recently opened an operations center in Dalian, China to address the IT support needs of pharmaceutical companies doing business in the main Asian markets.  In his role Mr. Song will support C3i's strategy to expand its clinical and commercial solutions to pharmaceutical, biotechnology and clinical research organizations in Asia.

Jonathan Song studied clinical medicine specializing in surgery in medical school at the Shanghai Jiaotong University in China and received his masters degree in management from Rensselaer Polytechnic Institute in the USA. He has 20 years of pharmaceutical and healthcare experience in China and the USA, both in industry and agency.

Mr. Song specializes in sales & marketing, professional promotion, business development, sales force effectiveness, resource allocation, budgeting and cost control, process improvement and branding management. He has worked for some of the biggest names in the industry, including Merck and Sinopharm, the biggest healthcare group in China. Mr. Song also has many years of experience of strategic business planning, business operations management, industry analysis, business intelligence, strategic management consulting, customer relationship management (CRM) and sales force automation (SFA)  in pharmaceutical and healthcare industries.

"We are excited to welcome Jonathan as the newest team member of our global team." - said Dave Hanaman, chief sales and marketing officer and co-founder at C3i. "His professionalism, customer-focus, and innovative approach to business development will catalyze our growth in Asia and help us to meet our customers' unique needs in this important and rapidly evolving market."

About C3i:
Headquartered in Morristown, New Jersey, C3i Inc. has global operations in the North America, Europe, India, and now China. Their 1400 employees provide technology training, multi-lingual service desk, hardware provisioning, and break/fix, asset management, and user/application administration services for pharmaceutical sales and clinical professionals worldwide. To learn more, visit www.c3i-inc.com.

Contact:
Dave Hanaman
C3i
973-401-4677
[email protected]

SOURCE C3i, Incorporated

Suggested Articles

Nearly two years after raising $75 million, iTeos Therapeutics is picking up $125 million to push its lead assets through phase 1/2 trials.

Bristol Myers Squibb and bluebird bio filed their BCMA-targeting CAR-T therapy for FDA approval, teeing it up for a potential green light in 2020.

With case counts surging and top officials infected, the U.K. is joining the testing for Gilead Sciences' much-hyped antiviral candidate remdesivir.